Kura Oncology is down 31% since CEO Troy Edward Wilson's $1.2M purchase
- Insider
- Troy Edward Wilson
- Role
- President and CEO
- Company
- Kura Oncology, Inc. (KURA)
- Transaction
- Buy
- Shares
- 100,000
- Amount
- $1.2M
- Trade date
- Aug 24, 2026
- Filed
- Aug 24, 2026, 0 days after the trade
- Source
- SEC Form 4 ↗
Troy Edward Wilson, President and CEO of Kura Oncology, Inc., bought 100,000 shares at $12.39 on August 24, 2026, for a total of $1.2M. The purchase was reported to the SEC 0 days after the trade.
Kura Oncology closed at $9.36 on October 19, 2026, 31.1% below the first close after the purchase ($13.59 on Aug 25, 2026). The share first closed 30% or more below that level on October 16, 2026. No sales by Troy Edward Wilson in the company have been reported since.
KURA −2.8% on the day, close Oct 30
Since purchase−31.1%$13.59 → $9.36
Since filing−31.1%$13.59 on Aug 25 → $9.36
Purchase$1.2M100,000 shares on Aug 24, 2026
Days since purchase56No sales by this filer since
Price since the purchase
Daily close · USD0%
−30%
Aug 25 · first close $13.59Oct 19 · $9.36
PurchaseFirst close below −30%